Literature DB >> 7768626

Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production.

T Jouault1, G Lepage, A Bernigaud, P A Trinel, C Fradin, J M Wieruszeski, G Strecker, D Poulain.   

Abstract

Different cell wall components from Candida albicans have been shown to stimulate murine macrophages for tumor necrosis factor alpha (TNF-alpha) secretion. All of these molecules contain beta-1,2-oligomannosides. In order to examine their role in TNF-alpha production, acid-labile oligosaccharides, released from C. albicans VW32 cell wall phosphopeptidomannan by mild acid hydrolysis, and previously shown to correspond to homopolymers of beta-1,2-linked mannopyranosyl units, were separated by gel filtration chromatography according to their degree of polymerization. Murine macrophages incubated with purified oligomannosides (M2 to M8) released TNF-alpha to an extent which was dependent on, although not directly correlated with, the length of the mannosyl chain. Slight activity was observed with M4 and M5; M6 and M7 had virtually no effect, whereas M8 was associated with strong TNF-alpha release. This effect of M8 was dose dependent and was not altered by polymyxin B, known to interfere with lipopolysaccharide-induced TNF-alpha production. These results suggest that stimulation of TNF-alpha release by C. albicans glycoconjugates containing beta-1,2-linked oligomannosides may be due, at least in part, to the presence of these components.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768626      PMCID: PMC173316          DOI: 10.1128/iai.63.6.2378-2381.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Cytokines and anti-fungal immunity.

Authors:  J Y Djeu
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

2.  Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis.

Authors:  J K Czop; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans.

Authors:  E Blasi; L Pitzurra; M Puliti; L Lanfrancone; F Bistoni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Complete 1H- and 13C-resonance assignments for D-mannooligosaccharides of the beta-D-(1-->2)-linked series released from the phosphopeptidomannan of Candida albicans VW.32 (serotype A).

Authors:  C Faille; J M Wieruszeski; J C Michalski; D Poulain; G Strecker
Journal:  Carbohydr Res       Date:  1992-12-15       Impact factor: 2.104

5.  Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans.

Authors:  E Blasi; R Barluzzi; R Mazzolla; F Bistoni
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

6.  Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strain by the action of Zymolyase-100T.

Authors:  N Shibata; H Kobayashi; M Tojo; S Suzuki
Journal:  Arch Biochem Biophys       Date:  1986-12       Impact factor: 4.013

Review 7.  Cytokine mediators of septic infections in the normal and granulocytopenic host.

Authors:  A Waage; S Steinshamn
Journal:  Eur J Haematol       Date:  1993-05       Impact factor: 2.997

8.  Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice.

Authors:  S Steinshamn; A Waage
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages.

Authors:  T Jouault; A Bernigaud; G Lepage; P A Trinel; D Poulain
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

Review 10.  Modulation of immune responses by surface polysaccharides of Candida albicans.

Authors:  J Domer; K Elkins; D Ennist; P Baker
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug
View more
  27 in total

Review 1.  Candida albicans phospholipomannan: a sweet spot for controlling host response/inflammation.

Authors:  Chantal Fradin; Emerson Soares Bernardes; Thierry Jouault
Journal:  Semin Immunopathol       Date:  2014-11-14       Impact factor: 9.623

2.  Beta-1,2-mannosylation of Candida albicans mannoproteins and glycolipids differs with growth temperature and serotype.

Authors:  P A Trinel; T Jouault; J E Cutler; D Poulain
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

3.  Candida albicans-derived beta-1,2-linked mannooligosaccharides induce desensitization of macrophages.

Authors:  T Jouault; C Fradin; P A Trinel; D Poulain
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.

Authors:  Y Han; T Kanbe; R Cherniak; J E Cutler
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 5.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

6.  Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis.

Authors:  K C Hazen; J G Wu; J Masuoka
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 7.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

8.  Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice.

Authors:  M G Netea; P N Demacker; N de Bont; O C Boerman; A F Stalenhoef; J W van der Meer; B J Kullberg
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 9.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

10.  Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease.

Authors:  Zsolt Barta; István Csípõ; Gábor G Szabó; Gyula Szegedi
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.